Get the up-to-date Trade Name Argatroban - accessdata fda 2024 now

Get Form
Trade Name Argatroban - accessdata fda Preview on Page 1

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

The easiest way to modify Trade Name Argatroban - accessdata fda in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Working on paperwork with our feature-rich and user-friendly PDF editor is easy. Follow the instructions below to fill out Trade Name Argatroban - accessdata fda online easily and quickly:

  1. Sign in to your account. Log in with your email and password or create a free account to try the product prior to choosing the subscription.
  2. Upload a form. Drag and drop the file from your device or add it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit Trade Name Argatroban - accessdata fda. Quickly add and underline text, insert pictures, checkmarks, and symbols, drop new fillable areas, and rearrange or delete pages from your paperwork.
  4. Get the Trade Name Argatroban - accessdata fda completed. Download your adjusted document, export it to the cloud, print it from the editor, or share it with other participants using a Shareable link or as an email attachment.

Take advantage of DocHub, the most straightforward editor to rapidly manage your paperwork online!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
Argatroban is a non-heparin anticoagulant shown to both normalize platelet count in patients with HIT and prevent the formation of thrombi. Parental anticoagulants must be stopped and a baseline activated partial thromboplastin time must be obtained prior to administering argatroban.
7.2 FDA Pharmacological Classification Argatroban is an Anti-coagulant and Direct Thrombin Inhibitor. The mechanism of action of argatroban is as a Thrombin Inhibitor.
This medicine may increase your chance of bleeding. Check with your doctor right away if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin. Avoid picking your nose.
The recommended steady-state plasma argatroban concentration target is 0.51.0 g/ml, which corresponds to a thrombin time range of 80120 s (based on their thrombin time, performed using a final thrombin concentration of 1.25 u/ml).
Argatroban is a synthetic monovalent direct thrombin inhibitor, the molecular structure of which contains an arginine residue. Argatroban is highly selective for thrombin and has little or no effect on related serine proteases (trypsin, factor Xa, plasmin, and kallikrein).
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

There are three types of DTIs, dependent on their interaction with the thrombin molecule. Bivalent DTIs (hirudin and analogs) bind both to the active site and exosite 1, while univalent DTIs bind only to the active site. The third class of inhibitors, which are gaining importance recently, is the allosteric inhibitors.
Standard Argatroban Infusion is 250mg in Normal Saline 250mL, yielding a concentration of 1 mg/mL or 1000 mcg/mL. 2. Therapeutic Goal Range for PTT is 55-100.
The solution is ready for intravenous infusion. Argatroban is contraindicated in: Patients with major bleeding, Patients with a history of hypersensitivity to argatroban.
Argatroban is available as an intravenous solution of 1 mg/ml. Monitoring: Monitor aPTT (target range of 1.5 to 3 times of initial baseline, not to exceed 100 seconds). Dosage adjustment: Adjust the dose (not to exceed 10 mcg/kg/min) to maintain aPTT in the target range.
Argatroban is a medication used to manage heparin-induced thrombocytopenia (HIT), which is a rare, life-threatening complication of heparin therapy. It is a direct thrombin inhibitor, a class of anticoagulant drugs.

Related links